Brief: Protillion Biosciences Announces Drug Discovery Collaboration With Merck
BRIEF-Protillion Biosciences Announces Drug Discovery Collaboration With Merck June 16 (Reuters) - Merck & Co Inc MRK.N:
PROTILLION BIOSCIENCES ANNOUNCES DRUG DISCOVERY COLLABORATION WITH MERCK
PROTILLION BIOSCIENCES: UNDER TERMS OF AGREEMENT, PROTILLION WILL RECEIVE AN UNDISCLOSED UPFRONT PAYMENT
PROTILLION BIOSCIENCES: UNDER TERMS, CO ELIGIBLE TO RECEIVE MILESTONE PAYMENTS OF UP TO $510 MILLION FOR SUCCESSFUL DEVELOPMENT OF MULTIPLE THERAPIES
Source text: ID:nBw6t6YbWa
Further company coverage: MRK.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Merck & Co
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials